Filing Flows › Cannapharmarx (CPMD) › Q2 2025
Cannapharmarx (CPMD) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 14, 2025
Cannapharmarx (CPMD) reported revenue of $232K for the second quarter 2025 (Q2 2025) and -31% from the quarter before. Operating margin was -363.1%, net loss $1.4M (610.3% of revenue).
Cannapharmarx, Q2 2025: revenue $232K, operating margin -363.1%, net loss $1.4M, operating cash flow −$446K. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $232K | -31% | — |
| Operating profit | −$841K | — | — |
| Net earnings | −$1.4M | — | — |
| Operating cash flow | −$446K | — | — |
What changed
Revenue was $232K in Q2 2025, down 31% from the previous quarter.
Operating costs exceeded revenue by $841K, an operating margin of -363.1%. The quarter ended with a net loss of $1.4M, wider than the previous quarter's $691K loss.
Operating cash flow was −$446K. Working capital and other items added $1.0M.
Questions
What was Cannapharmarx's revenue in the second quarter 2025?
Cannapharmarx (CPMD) reported revenue of $232K for the second quarter 2025 (Q2 2025) and -31% from the quarter before.
Was Cannapharmarx profitable in the second quarter 2025?
Operating loss was $841K (-363.1% of revenue) and net loss $1.4M.
Source: Cannapharmarx 10-Q on SEC EDGAR.